(Q67985870)
Statements
Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-life (English)
C J Weinheimer
H L James
N K Kalyan
J Wilhelm
S G Lee
P P Hung
B E Sobel